Symbol="CRSP"
AssetType="Common Stock"
Name="Crispr Therapeutics AG"
Description="CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. The company is headquartered in Zug, Switzerland."
CIK="1674416"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="BAARERSTRASSE 14, ZUG, CH"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="3799936000"
EBITDA="-452763008"
PERatio="None"
PEGRatio="0"
BookValue="22.88"
DividendPerShare="0"
DividendYield="0"
EPS="-6.57"
RevenuePerShareTTM="2.166"
ProfitMargin="-2.445"
OperatingMarginTTM="-2.784"
ReturnOnAssetsTTM="-0.127"
ReturnOnEquityTTM="-0.213"
RevenueTTM="170100000"
GrossProfitTTM="-570697000"
DilutedEPSTTM="-6.57"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="442.04"
AnalystTargetPrice="85.92"
TrailingPE="-"
ForwardPE="23.36"
PriceToSalesRatioTTM="253.26"
PriceToBookRatio="2.011"
EVToRevenue="178.1"
EVToEBITDA="-3.434"
Beta="1.614"
num_52WeekHigh="75.18"
num_52WeekLow="38.94"
num_50DayMovingAverage="55.36"
num_200DayMovingAverage="52.57"
SharesOutstanding="78935000"
DividendDate="None"
ExDividendDate="None"
symbol="CRSP"
open="46.66"
high="49.18"
low="46.55"
price="48.14"
volume="1207759.00"
latest_trading_day="2023-08-18"
previous_close="47.09"
change="1.05"
change_percent="2.2298%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="36"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="64"
Volume_recent_avg="1262330"
Change_recent_avg="-0.11"
Delta_recent_avg="2.74"
Variance_recent_avg="1.37"
Change_ratio_recent_avg="-0.22"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="64"
Aroon_momentum_negative="36"
image_negative_thumbnail_id_1="128"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0048.jpeg"
image_negative_thumbnail_id_2="1124"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0157.jpeg"
image_neutral_thumbnail_id_1="555"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0044.jpeg"
image_neutral_thumbnail_id_2="566"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_positive_thumbnail_id_1="618"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0090.jpeg"
image_positive_thumbnail_id_2="707"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0001.jpeg"
image_professor_thumbnail_id_1="1193"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
image_professor_thumbnail_id_2="1186"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
